A five-day course of ivermectin may reduce the duration of COVID-19 illness

Int J Infect Dis. 2021 Sep:110:93-94. doi: 10.1016/j.ijid.2021.07.050. Epub 2021 Jul 26.
No abstract available

Keywords: COVID-19; antiviral effect; ivermectin.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Humans
  • Ivermectin*
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Ivermectin